Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.1.27.4 (
ribonuclease
)
6,621
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The most attractive feature of
SDA
is its operation at a single temperature, which removes the need for instrumented temperature cycling as with PCR and the ligase chain reaction. Highly reproducible temperature profiles, over a large array of samples, can burden the accuracy and expense of an amplification technique. However, the expense of a temperature cycler is offset somewhat by the cost of additional enzymes used in isothermal techniques. In comparisons with isothermal, transcription-based techniques,
SDA
requires fewer enzymes and has a simpler mechanism.
SDA
may also be more robust than transcription-based processes because it is not susceptible to contaminating
ribonuclease
activity. This is generally more of a concern when using clinical samples. The most significant disadvantage of
SDA
is its inability to efficiently amplify long target sequences. Until this short-coming is eliminated,
SDA
will be assigned to the diagnostic laboratory along with the ligase chain reaction. Currently,
SDA
cannot compete with PCR in research applications such as the isolation of gene sequences. The second disadvantage of
SDA
is that it operates at relatively low (nonstringent) temperatures, which produces considerable background reactions. Consequently,
SDA
reaction products cannot be analyzed routinely by ethidium-stained gel electrophoresis, as is used commonly with PCR, unless the target sample contains a large number of initial targets.
...
PMID:Empirical aspects of strand displacement amplification. 822 Jan 81